Report: US cancels vaccine maker’s multimillion dollar deal
The federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland- based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated vaccine doses this spring.
How long after exposure to COVID can a test detect the virus? When should I get my booster shot?
Since the coronavirus pandemic began, Dr. Frank McGeorge has been keeping viewers up-to-date and informed on all fronts. He’s been answering your questions about the vaccine, the vaccination process and more.
ICU's around U.S. reaching dangerous capacity levels from COVID-19 surge
We've hit a grave new milestone in the fight against COVID-19, one in 500 people in the U.S. has now died from the virus. The news comes as ICU beds around the country continue to fill fast with unvaccinated COVID patients, leaving little room for those with other health emergencies. Manuel Bojorquez reports.
news.yahoo.com90 million Americans receive coronavirus vaccine
90 million Americans receive coronavirus vaccine Nearly 90 million Americans have received at least one dose of a COVID-19 vaccine. In hard-hit California, 10 million have received one or both doses. The news comes amid increased warnings that now is not the time for states to let down their guard. Danya Bacchus reports.
cbsnews.comFDA approves Moderna coronavirus vaccine
FDA approves Moderna coronavirus vaccine A second COVID-19 vaccine has been approved for distribution in the U.S. The FDA’s approval of Moderna’s vaccine Friday night clears the way for the pharmaceutical company to immediately ship millions of doses, likely beginning with hospitals. Tom Hanson is following the developments.
cbsnews.comFDA says Moderna's coronavirus vaccine is highly effective
FDA says Moderna's coronavirus vaccine is highly effective Moderna's coronavirus vaccine could soon be part of America's largest mass vaccination effort. The Food and Drug Administration said the vaccine is highly effective and there are "no specific safety concerns," and a panel is expected to consider the pharmaceutical company's application for emergency use this week. This comes as distribution ramps up for Pfizer's vaccine and health care systems are stretched thin as coronavirus infections skyrocket. CBS News correspondent Mola Lenghi reports on the latest developments from New York City, CBS News chief congressional correspondent Nancy Cordes reports from Washington on the need for funding to fight COVID-19, and Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and the former acting director of the Centers for Disease Control and Prevention, joined CBSN to discuss.
cbsnews.com